iTrack™: A Revolutionary Solution for Glaucoma Treatment
. iTrack™ is an innovative device designed to redefine minimally invasive glaucoma treatment (MIGS).
With advanced technology, it offers an effective and safe approach to restoring the natural flow of aqueous humour, reducing intraocular pressure (IOP) without the need for implantable devices or removal of eye tissue.
The flexibility of iTrack™ allows it to be applied to a wide range of patients, from mild to advanced cases. The procedure is quick, performed on an outpatient basis, and promotes a more comfortable patient recovery.
With more than 100,000 patients treated worldwide, iTrack™ is a real breakthrough for ophthalmologists looking for effective, personalised solutions that prioritise patient well-being.
Whether to reduce dependence on eye drops, or as an alternative to more invasive interventions, iTrack™ is the smart choice for a modern approach to glaucoma.
Goldfarma Comércio de Produtos Farmacêuticos Lda., has notified Infarmed within the scope of the exercise of the activities of Distribution of Medicines and Medical Devices. NIPC 507372328
Goldfarma Comércio de Produtos Farmacêuticos Lda., has notified Infarmed within the scope of the exercise of the activities of Distribution of Medicines and Medical Devices. NIPC 507372328
goldfarma © 2025 all rights reserved
